Oral Cholesteryl Ester Transfer Protein (CETP) Inhibitors: A Potential New Approach for Treating Coronary Artery Disease

This publication has 81 references indexed in Scilit:

• Inflammation, Atherosclerosis, and Coronary Artery Disease
  New England Journal of Medicine, 2005
• Lipid transfer proteins (LTP) and atherosclerosis
  Atherosclerosis, 2005
• A review of CETP and its relation to atherosclerosis
  Journal of Lipid Research, 2004
• JTT-705
  Drugs of the Future, 2004
• Association of Cholesteryl Ester Transfer Protein– Taq IB Polymorphism With Variations in Lipoprotein Subclasses and Coronary Heart Disease Risk
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2000
• Stereoselective Mukaiyama-Michael/Michael/Aldol Domino Cyclization as the Key Step in the Synthesis of Pentasubstituted Arenes: An Efficient Access to Highly Active Inhibitors of Cholesteryl Ester Transfer Protein (CETP)
  Angewandte Chemie International Edition in English, 1999
• Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels.
  Journal of Clinical Investigation, 1996
• Inactivation of Cholesteryl Ester Transfer Protein by Cysteine Modification
  Biochemical and Biophysical Research Communications, 1996
• Range of serum cholesterol values in the population developing coronary artery disease
  The American Journal of Cardiology, 1995
• Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol.
  Journal of Clinical Investigation, 1994